Nuveen Fund Advisors’s Merck MRK Stock Holding History

Nuveen Fund Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5,909	Closed	-$400K	–	86
2018 Q3	$400K	Sell	5,909 -3,554	-38%	-$226K	0.89%	39
2018 Q2	$548K	Sell	9,463 -2,998	-24%	-$169K	0.68%	51
2018 Q1	$648K	Sell	12,461 -2,152	-15%	-$116K	0.3%	103
2017 Q4	$785K	Sell	14,613 -9,361	-39%	-$519K	0.23%	126
2017 Q3	$1.47M	Sell	23,974 -6,028	-20%	-$365K	0.3%	106
2017 Q2	$1.83M	Sell	30,002 -17,959	-37%	-$1.09M	0.29%	108
2017 Q1	$2.91M	Sell	47,961 -31,752	-40%	-$1.93M	0.38%	91
2016 Q4	$4.48M	Sell	79,713 -27,156	-25%	-$1.59M	0.65%	35
2016 Q3	$6.36M	Sell	106,869 -10,539	-9%	-$616K	0.89%	18
2016 Q2	$6.45M	Buy	+117,408	New	+$6.25M	1%	16

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Fund Advisors's MRK Position: Q4 2018 in Review

Nuveen Fund Advisors sold out of Merck (MRK) in Q4 2018, closing a stake of 5,909 shares — an estimated $400K sold.

Nuveen Fund Advisors first reported a position in MRK in Q2 2016 and held it in 10 quarters. The position peaked at $6.45M in Q2 2016. 2,250 funds tracked by Wall St. Rank hold MRK as of Q4 2018.

Nuveen Fund Advisors reported no remaining Merck position as of Q4 2018 after selling out during the quarter.
Nuveen Fund Advisors sold 5,909 Merck shares in Q4 2018, an estimated $400K.
Nuveen Fund Advisors first reported a position in Merck in Q2 2016 and held it in 10 quarters.
Nuveen Fund Advisors's Merck position peaked at $6.45M in Q2 2016.
2,250 funds tracked by Wall St. Rank held Merck as of Q4 2018.

Based on Nuveen Fund Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.